Cara Therapeutics
CARA
#10367
Rank
A$12.21 M
Marketcap
A$8.01
Share price
-2.56%
Change (1 day)
1,813.29%
Change (1 year)

Cara Therapeutics (CARA) - Net assets

Net assets on the balance sheet as of December 2024 : -A$6.92 Million

According to Cara Therapeutics 's latest financial reports the company has -A$6.92 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Cara Therapeutics - Net assets on balance sheet (from 2012 to 2024)

Net assets by year

Year Net assets Change
2024-12-31$-A$7.39 Million-108.81%
2023-12-31$A$83.78 M-64.09%
2022-12-31$A$0.23 B-25.65%
2021-12-31$A$0.31 B-3.09%
2020-12-31$A$0.32 B21.43%
2019-12-31$A$0.26 B40.59%
2018-12-31$A$0.18 B70.65%
2017-12-31$A$0.11 B57.96%
2016-12-31$A$70.37 M-51.2%
2015-12-31$A$0.14 B128.42%
2014-12-31$A$63.12 M389.16%
2013-12-31$A$12.9 M449.85%
2012-12-31$A$2.34 M-60.58%
2011-12-31$A$5.95 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Trevena
TRVN
-A$35.1 Million 407.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
A$21.23 M-407.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$140.15 B-2,027,010.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$119.35 B-1,726,139.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-A$0.28 Billion 3,944.65%๐Ÿ‡บ๐Ÿ‡ธ USA